100 related articles for article (PubMed ID: 16332985)
1. Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell lines.
Wallqvist A; Connelly J; Sausville EA; Covell DG; Monks A
Mol Pharmacol; 2006 Mar; 69(3):737-48. PubMed ID: 16332985
[TBL] [Abstract][Full Text] [Related]
2. Technology evaluation: SAGE, Genzyme molecular oncology.
Bartlett J
Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
Ooyama A; Takechi T; Toda E; Nagase H; Okayama Y; Kitazato K; Sugimoto Y; Oka T; Fukushima M
Cancer Sci; 2006 Jun; 97(6):510-22. PubMed ID: 16734730
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
5. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
6. Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.
Whyte DB; Holbeck SL
Biochem Biophys Res Commun; 2006 Feb; 340(2):469-75. PubMed ID: 16376301
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
[TBL] [Abstract][Full Text] [Related]
8. Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancer.
Szakács G; Gottesman MM
Mol Interv; 2004 Dec; 4(6):323-5. PubMed ID: 15616161
[TBL] [Abstract][Full Text] [Related]
9. Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
Györffy B; Serra V; Materna V; Schäfer R; Dietel M; Schadendorf D; Lage H
Melanoma Res; 2006 Apr; 16(2):147-55. PubMed ID: 16567970
[TBL] [Abstract][Full Text] [Related]
10. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of differential expression genes related to different metastasis potential of adenoid cystic carcinoma using restriction fragments differential display PCR].
Lu YG; Zhou HY; Ding LC; Mei Y; Xiong RH; Deng SS; Yang HJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):505-10. PubMed ID: 17029196
[TBL] [Abstract][Full Text] [Related]
12. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
Huang R; Wallqvist A; Thanki N; Covell DG
Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
[TBL] [Abstract][Full Text] [Related]
13. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
14. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole.
Monks A; Harris E; Hose C; Connelly J; Sausville EA
Mol Pharmacol; 2003 Mar; 63(3):766-72. PubMed ID: 12606787
[TBL] [Abstract][Full Text] [Related]
15. Comparison of microarray and sage techniques in gene expression analysis of human glioblastoma.
Kavsan VM; Dmitrenko VV; Shostak KO; Bukreieva TV; Vitak NY; Simirenko OE; Malisheva TA; Shamayev MI; Rozumenko VD; Zozulya YA
Tsitol Genet; 2007; 41(1):36-55. PubMed ID: 17427416
[TBL] [Abstract][Full Text] [Related]
16. Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy.
Kumagai K; Nimura Y; Mizota A; Miyahara N; Aoki M; Furusawa Y; Takiguchi M; Yamamoto S; Seki N
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2300-4. PubMed ID: 16723437
[TBL] [Abstract][Full Text] [Related]
17. [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
Feng B; Zhao YP; Chen G; Zhang TP; Wu YD
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1629-33. PubMed ID: 18453221
[TBL] [Abstract][Full Text] [Related]
18. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
Yamori T
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen.
Huang R; Wallqvist A; Covell DG
Genomics; 2006 Mar; 87(3):315-28. PubMed ID: 16386875
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
